FGP
AEHR icon

Freestone Grove Partners’s Aehr Test Systems AEHR Stock Holding History

Freestone Grove Partners’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
+1,970
New +$180K ﹤0.01% 798

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freestone Grove Partners's AEHR Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 1,970 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #798 among its holdings.

262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Freestone Grove Partners held 1,970 shares of Aehr Test Systems worth $189K as of Q2 2026.
  • Aehr Test Systems was a new Freestone Grove Partners position in Q2 2026.
  • Aehr Test Systems made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #798 holding.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.